D8-MMAE

D8-MMAE Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:MMAE-d8;D8-Monomethyl auristatin E;D8-MMAE
CAS:2070009-72-0
Purity:98.00% Package:1 mg;10 mg;100 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Hangzhou Huarong Pharm Co., Ltd.
Tel: 571-86758373 +8613588754946
Email: sales@huarongpharm.com
Products Intro: Product Name:D8-MMAE
CAS:2070009-72-0
Purity:99% Package:1mg;0USD|10mg;0USD
Company Name: ChemExpress
Tel: +86-021-58950125 +86-021-58950125;
Email: info@chemexpress.com
Products Intro: Product Name:MMAE-d8
CAS:2070009-72-0
Purity:>=98% Package:10g
Company Name: Levena (Suzhou) Biopharma Co., Ltd.  Gold
Tel: 0512-81877925 051281877925
Email: info@levena.cn
Products Intro: Product Name:D8-Monomethyl auristatin E
CAS:2070009-72-0
Purity:>99% Package:1mg/RMB 8000;5mg/RMB 20000;10mg/RMB 35000
Company Name: Haoyuan Chemexpress Co., Ltd.  
Tel: 021-58950125
Email: info@chemexpress.com
Products Intro: Product Name:D8-MMAE
Purity:>98% Package:5500RMB/1mg

D8-MMAE manufacturers

  • D8-MMAE
  • D8-MMAE pictures
  • $0.00 / 1mg
  • 2021-09-16
  • CAS:2070009-72-0
  • Min. Order: 1mg
  • Purity: 99%
  • Supply Ability: 100KG
D8-MMAE Basic information
Product Name:D8-MMAE
Synonyms:D8-MMAE;D8-Monomethyl auristatin E;MMAE-d8;2H8]-MMAE;MMAE-d-8,MMAE d8,MMAEd8
CAS:2070009-72-0
MF:C39H59D8N5O7
MW:726.027874224
EINECS:
Product Categories:
Mol File:2070009-72-0.mol
D8-MMAE Structure
D8-MMAE Chemical Properties
storage temp. Store at -20°C,unstable in solution, ready to use.
solubility DMSO : 100 mg/mL (137.74 mM; Need ultrasonic)
form Solid
color White to off-white
Safety Information
MSDS Information
D8-MMAE Usage And Synthesis
Biological ActivityD8-MMAE (D8-Monomethyl auristatin E) is a deuterated labeled MMAE. MMAE is a tubulin inhibitor that inhibits mitosis.
in vivo

Intratumoral MMAE concentrations consistently correlates with the extent of tumor growth inhibition in tumor xenograft models. IHC analysis reveals that nonbinding control-treated tumors consist of both CD30 + and CD30 - cells, presumably because they do not kill either CD30 + or CD30 - Karpas 299 cells. Only CD30 - cells are found in cAC10-vcMMAF-treated tumors, illustrating that cAC10-vcMMAF eliminates most CD30 + cells. Interestingly, the two tumors that relapses from cAC10-vcMMAE treatment are also found to be CD30 - by the end of study, indicating a small fraction of CD30 - cells might have escaped from bystander killing in these two remaining tumors.

p>
target

Auristatin

D8-MMAE Preparation Products And Raw materials
Tag:D8-MMAE(2070009-72-0) Related Product Information
Propylthiouracil